PHARMA NEWS, MULT...
Follow
Find
30.4K views | +140 today

5 Reasons Pharma Should Reconsider Instagram

From www.intouchsol.com

More and more, Instagram is becoming a viable social channel for pharma, if used in the right way. So here are five reasons we believe pharmas should take a new look at Instagram.

No comment yet.

» « Bien vivre mon diabète » : Roche Diabetes Care France lance sa page Facebook

From www.mypharma-editions.com

Roche Diabetes Care France vient d'ouvrir la page Facebook « Bien vivre mon diabète ». Ce nouvel espace d’informations et d’échanges a pour objectif de faciliter le quotidien des patients diabétiques et d’améliorer leur qualité de vie, leur autonomie, leur confort et leur mobilité.
No comment yet.

Santé connectée: « Sanofi est à l'avant-garde de cette révolution »

From www.latribune.fr

Gilles Litman explique pour La Tribune comment le premier groupe pharmaceutique français veut développer une véritable stratégie e-santé pour compléter son offre médicamenteuse et auréoler son image d'une forte composante 2.0.
No comment yet.

Big Data et pharmacie : Roche s'inocule de nouvelles données

From www.silicon.fr

En plus des essais cliniques, les laboratoires Roche vont manipuler des données retraçant les effets de ses molécules sur la durée.
No comment yet.

Transformation digitale de l'industrie : une opportunité à 1 250 milliards d'euros | L'Atelier : Accelerating Business

From www.atelier.net

Roland Berger estime que si le secteur industriel européen rate son tournant numérique, il engrangerait une perte de plus de 605 milliards d'euros d'ici 2025.
No comment yet.

Which #Pharma Companies are BIG in Social Media Engagement? Hint: Doesn't Correlate with Sales!

From www.slideshare.net

Ogilvy CommonHealth Worldwide evaluated  how  14 major pharma companies  were  performing  across  six  key  categories:  


  1. Social presence: How  many  social  networks  was  the  company  on?   
  2. Activity: Was  the  content  kept  fresh  with  regular  updates?
  3. Engagement: Were  the  companies    engaging  their  users  and  generating interest?    
  4. Social network: How  simple  and  intuitive  was  the   connection  between  social  networks?    
  5. Virality: Was  the  content  spread  around   the  social  sphere?
  6. Sommunity Size: How  big  was  the  community?
No comment yet.

Stop, Collaborate and Listen: The Social Lives of Healthcare Professi…

From www.slideshare.net

Shwen Gwee's keynote presentation from the BDI "Future of Healthcare Professionals Collaboration Leadership Luncheon" hosted by Within3
No comment yet.

The Dilemma of the Tablet-Enabled Physician | Physicians Practice

From www.physicianspractice.com

"I value my time off. Years ago when first going onto EHR, I could not connect from my house so I learned to get everything done before leaving the office. My time off was truly unconnected. This EHR change to mobile is going to necessitate another change in work flow for me.

There are two ways to approach this subject:

1. It will allow me to follow my patients more closely since I can get their lab results and follow-up data without being in the office. This will improve my relationship with my patients and result in more detailed care for them.

2. I will never really be out of the office. This could have legal ramifications.

The answer will likely be having a better buddy system and sign-out criteria in our practice. Right now, I have a buddy that will keep an eye on my charts and labs when I am away. We try to notify our buddies when they need to take over. Sometimes, it doesn't always work that way. So far, nothing serious has gotten missed … but we must remain vigilant in making sure follow up happens."

No comment yet.

Why Pharma companies have no substantial impact on the mHealth app economy #pharma #hcsmeu

From research2guidance.com

Leading Pharma companies fail, to have a significant impact on the mHealth app market. More than 100 available apps have generated only limited reach.
No comment yet.

L'industrie pharmaceutique parie sur une médecine de plus en plus personnalisée #hcsmeufr

From www.ladepeche.fr

(AFP) - La médecine personnalisée, qui vise à proposer des traitements adaptés à chaque patient, continue à se développer contre le cancer, mais concerne désormais aussi des maladies chroniques comme le diabète, et pourrait même trouver des ...
No comment yet.

Determining How Much Pharma Spends on Internet vs. TV DTC Advertising is a Daunting Task!

From pharmamkting.blogspot.com

I prepared the chart on the left for the Pharma Marketing News article "DTC Ad Spending Rises from the Grave," which was published this Monday. You should compare this version of the chart to the one I published here on Pharma Marketing Blog last week (here). 

This chart says 5% of pharma's 2014 DTC ad budget went to the Internet (excluding search), whereas the previous version says only 3%. 

This chart says 63% of the budget went to TV, whereas the previous version says 70%. 

I'll ignore print for now. 

Determining the exact amount that the pharmaceutical industry spends on advertising via different media (TV, print, Internet, etc.) is a daunting task. Numbers regarding pharma DTC spending come from two sources: Nielsen and Kantar Media. Both report "measured media" spending, which includes TV, magazines, news-papers, radio, outdoor, and Internet (display ads only, not including search). Kantar tracks over 3,000 media sources throughout the US and Canada, which is a different methodology than that used by Nielsen. As a result, the numbers from these sources often do not match (for more on that, read "Making Sense of Pharma DTC Spending Trends"). 

Why the Differences?


Read more here.

No comment yet.

The Digital Divide in pharma

From www.a-cross.com

Across Health blog: the Digital Divide in pharma: HCPs’ needs exceed pharma’s digital offerings, particularly in the medical space. Want to learn more?
No comment yet.

UCB leads "epilepsy hackathon

From www.ucb.com

Hack Epilepsy will bring together developers, designers and digital experts, along with healthcare providers and patients to imagine new ways of applying digital technologies that can make a real difference for the epilepsy community.

Jurjen Söhne's curator insight, April 16, 2:16 AM

Hack Epilepsy will bring together developers, designers and digital experts, along with healthcare providers and patients to imagine new ways of applying digital technologies that can make a real difference for the epilepsy community

How Pfizer Canada is Leading the Pharmaceutical Market in Social Media

From blog.hootsuite.com

Learn how Heather Bisset has found a solution to manage corporate reputation and customer relationships with strategy for corporate social media accounts.
No comment yet.

Patients do not feel connected to pharma

From www.mmm-online.com

About 25% of patients do not feel connected to the companies that make the medications they depend on for one key reason: They do not see themselves in the marketing with which brands expect to reach them
No comment yet.

IBM Teams up with Medtronic, Apple, and J&J; Formally Enters Health Market | MDDI Medical Device and Diagnostic Industry News Products and Suppliers

From www.mddionline.com

Arundhati Parmar IBM announced Tuesday that it has formally created a business unit called IBM Watson Health, based in Boston, that will execute on its overarching goal to transform personal healthcare. To that end, the company is also launching the Watson Health Cloud to "provide a secure and open platform for physicians, researchers, insurers and companies focused on health and wellness solutions," a news release stated.
No comment yet.

Customization: Why healthcare brands should get personal

From medcitynews.com

Healthcare, pharmaceutical and insurance companies can solve the needs of consumers by drawing inspiration from some of the most innovative companies in the world, both in and outside of the...
No comment yet.

AstraZeneca To Use Patient-Reported Data From PatientsLikeMe for Pharma Research

From hitconsultant.net

PatientsLikeMe announced this morning a five-year agreement with AstraZeneca to provide patient-reported data in support of the pharmaceutical company’s research initiatives. This is a first of its kind agreement for AstraZeneca and signals an...
No comment yet.

Des médicaments remboursés en cas d'inefficacité

From www.francetvinfo.fr

Les laboratoires pharmaceutiques peuvent désormais rembourser l'Assurance maladie en cas d'échec de certains traitements.
No comment yet.

Is Digital Marketing Doing More Harm Than Good for Pharma?

From prolifiq.com

Pharma has certainly ramped up digital campaigns, but the rapid adoption may not be an advantage for all Pharma companies.
No comment yet.

#Pharma Mobile Health Apps: If You Build Them, ...

From www.scoop.it

It’s hard to find a pharma or medical device company these days that doesn’t have at least one mobile app in development. And now that, as of February 2015, the U.S.
No comment yet.

Le "numérique déroutant" résumé en une infographie par Bpifrance Le Lab

From www.usine-digitale.fr

Le numérique, qui représente 5,5% du PIB et 3,3% des emplois en France, est une formidable opportunité à saisir... mais aussi une source de boulversement pour toutes les industries "traditionnelles", et en particulier les PME et ETI. Bpifrance Le Lab résume les grands mouvements à l'oeuvre dans une infographie.
No comment yet.

#Pharma Mobile Health Apps: If You Build Them, Will Physicians "Prescribe" Them?

From hitconsultant.net

It’s hard to find a pharma or medical device company these days that doesn’t have at least one mobile app in development. And now that, as of February 2015, the U.S. Food and Drug Administration (FDA) has issued guidance on which apps need to be regulated and which ones don’t, it will be interesting to see if this almost exponential development trend continues.


Federal guidance alone doesn’t guarantee an app’s success, and there is still plenty of playing field for developers in the health and wellness space for apps that do not require 510(k) submission. Therefore, developers and marketers alike must keep in mind these three key drivers of mobile health app adoption.


Awareness

In a 2014 poll by QuantiaMD, only 37% of physicians surveyed said that they had recommended a mobile app to their patients. In another QuantiaMD poll, 42% of physicians said they would notrecommend a mobile health app to patients because there was no regulatory oversight (though the new FDA guidance should help with this). In addition, another 37% percent had no idea what mobile health apps are out there.


In spite of physicians being split on the utility of apps, consumers are downloading them at a rapid pace. In fact, it is estimated that within the next three years half of all smartphone and tablet users will have at least one mobile health or wellness app, like Lose It!, RunKeeper, or Glucose Buddy. But, downloading doesn’t necessarily mean they are using them! There is enormous opportunity for healthcare marketers to more effectively demonstrate the myriad of app benefits to patients and physicians alike.


More here...

Pharma Guy's curator insight, April 7, 7:19 AM


Experts say that the bulk of the apps recommended by physicians are related to diet and fitness, and that few physicians are “prescribing” apps with the expectation of receiving follow-up data. See here: http://sco.lt/5igoc5